Search Results 851-860 of 18142 for monoclonal antibody

1. Mayo Clinic Q&A podcast: Covering COVID-19 in 2021

   Now we have three vaccines in the U.S., and antiviral and monoclonal antibody treatments. That's really incredible." Despite the rapid scientific ...

2. A Study Of Pirtobrutinib And Brexucabtagene Autoleucel In Relapsed Or Refractory Mantle Cell Lymphoma - Mayo Clinic

   Targeted agents (i.e. BTK inhibitors), investigational agents, therapeutic monoclonal antibodies ... Antibody-drug conjugates (ADC): 10 weeks. Radiation ...

3. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

4. Study Of Imprime PGG And Pembrolizumab In Advanced Melanoma And Triple Negative Breast Cancer - Mayo Clinic

   Had a prior anti-cancer monoclonal antibody (except immune CPI in the case of melanoma subjects) within 30 days prior to start of study treatment, or ...

5. Hematology - Clinical trials

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

6. Oncology (Medical) - Clinical trials

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

7. Lung transplant - Mayo Clinic

   Monoclonal antibody. Basiliximab (Simulect) is an immunosuppressant that may be given during the first few days after surgery to prevent rejection ...

8. Personalized Neoantigen Peptide-Based Vaccine In Combination With Pembrolizumab For Treatment Of Advanced Solid Tumors - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Liver Cancer Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

10. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    * Any previous treatment with anti-CD19 antibody, complement inhibitors, neonatal Fc receptor antagonists, anti-B-lymphocyte stimulator monoclonal antibody * ...